- This just in July 30
Pharmaceutical giant Pfizer Inc. agreed Wednesday to buy the vaccines unit of Baxter International Inc. in a $635 million deal, Reuters reports.
Through the acquisition, Pfizer will have access to Baxter's meningitis vaccine and its encephalitis vaccine, both of which are currently available outside of the United States. Pfizer will also gain access to part of Baxter's vaccine production facility in Austria.
Pfizer's global vaccines business reported sales of $1.1 billion in the second quarter, while Baxter's international vaccines sales totaled $110 million in the same timeframe. The deal is expected to close by the end of the year.- -
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- Syrian women know how to defeat ISIS
- The U.S. Marines are developing laser weapons. Here's why.
- The one thing the New Atheists get right about religion
- 43 TV shows to watch in 2014
- How to be the most productive person in your office — and still get home by 5:30 p.m.
- Will Kobani be ISIS's Waterloo?
- How 1,000-year lifespans could remake the economy
- 5 baffling foreign-language versions of the Fresh Prince of Bel-Air theme song
- Bob Odenkirk's 6 favorite books
- The stories behind 22 classic album covers
Subscribe to the Week